FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2140492749> ?p ?o ?g. }

• W2140492749 endingPage "670" @default.
• W2140492749 startingPage "661" @default.
• W2140492749 abstract "Based on the previously described roles of doxorubicin in immunogenic cell death, both doxorubicin and liposomal doxorubicin (Doxil) were evaluated for their ability to boost the antitumor response of different cancer immunotherapies including checkpoint blockers (anti–PD-L1, PD-1, and CTLA-4 mAbs) and TNF receptor agonists (OX40 and GITR ligand fusion proteins) in syngeneic mouse models. In a preventative CT26 mouse tumor model, both doxorubicin and Doxil synergized with anti–PD-1 and CTLA-4 mAbs. Doxil was active when CT26 tumors were grown in immunocompetent mice but not immunocompromised mice, demonstrating that Doxil activity is increased in the presence of a functional immune system. Using established tumors and maximally efficacious doses of Doxil and cancer immunotherapies in either CT26 or MCA205 tumor models, combination groups produced strong synergistic antitumor effects, a larger percentage of complete responders, and increased survival. In vivo pharmacodynamic studies showed that Doxil treatment decreased the percentage of tumor-infiltrating regulatory T cells and, in combination with anti–PD-L1, increased the percentage of tumor-infiltrating CD8+ T cells. In the tumor, Doxil administration increased CD80 expression on mature dendritic cells. CD80 expression was also increased on both monocytic and granulocytic myeloid cells, suggesting that Doxil may induce these tumor-infiltrating cells to elicit a costimulatory phenotype capable of activating an antitumor T-cell response. These results uncover a novel role for Doxil in immunomodulation and support the use of Doxil in combination with checkpoint blockade or TNFR agonists to increase response rates and antitumor activity." @default.
• W2140492749 created "2016-06-24" @default.
• W2140492749 creator A5001220282 @default.
• W2140492749 creator A5002515746 @default.
• W2140492749 creator A5015608281 @default.
• W2140492749 creator A5019761569 @default.
• W2140492749 creator A5034002721 @default.
• W2140492749 creator A5035878833 @default.
• W2140492749 creator A5053179595 @default.
• W2140492749 creator A5053918852 @default.
• W2140492749 creator A5087353638 @default.
• W2140492749 date "2015-08-01" @default.
• W2140492749 modified "2023-10-04" @default.
• W2140492749 title "Doxil Synergizes with Cancer Immunotherapies to Enhance Antitumor Responses in Syngeneic Mouse Models" @default.
• W2140492749 cites W1484032922 @default.
• W2140492749 cites W1539480022 @default.
• W2140492749 cites W1573738975 @default.
• W2140492749 cites W1971932775 @default.
• W2140492749 cites W1976051281 @default.
• W2140492749 cites W1980181290 @default.
• W2140492749 cites W1992979622 @default.
• W2140492749 cites W1996828453 @default.
• W2140492749 cites W2004409905 @default.
• W2140492749 cites W2010183849 @default.
• W2140492749 cites W2016612145 @default.
• W2140492749 cites W2025038288 @default.
• W2140492749 cites W2026861011 @default.
• W2140492749 cites W2038218697 @default.
• W2140492749 cites W2059409197 @default.
• W2140492749 cites W2066555244 @default.
• W2140492749 cites W2081796577 @default.
• W2140492749 cites W2091103707 @default.
• W2140492749 cites W2094481139 @default.
• W2140492749 cites W2096751726 @default.
• W2140492749 cites W2104072610 @default.
• W2140492749 cites W2104578054 @default.
• W2140492749 cites W2106926141 @default.
• W2140492749 cites W2112069616 @default.
• W2140492749 cites W2119814497 @default.
• W2140492749 cites W2121046520 @default.
• W2140492749 cites W2133294507 @default.
• W2140492749 cites W2133924272 @default.
• W2140492749 cites W2134907223 @default.
• W2140492749 cites W2138170994 @default.
• W2140492749 cites W2139316892 @default.
• W2140492749 cites W2142153200 @default.
• W2140492749 cites W2145994992 @default.
• W2140492749 cites W2152155935 @default.
• W2140492749 cites W2158545805 @default.
• W2140492749 cites W2163895585 @default.
• W2140492749 cites W2995442355 @default.
• W2140492749 cites W52103172 @default.
• W2140492749 doi "https://doi.org/10.1016/j.neo.2015.08.004" @default.
• W2140492749 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4674486" @default.
• W2140492749 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26408258" @default.
• W2140492749 hasPublicationYear "2015" @default.
• W2140492749 type Work @default.
• W2140492749 sameAs 2140492749 @default.
• W2140492749 citedByCount "127" @default.
• W2140492749 countsByYear W21404927492016 @default.
• W2140492749 countsByYear W21404927492017 @default.
• W2140492749 countsByYear W21404927492018 @default.
• W2140492749 countsByYear W21404927492019 @default.
• W2140492749 countsByYear W21404927492020 @default.
• W2140492749 countsByYear W21404927492021 @default.
• W2140492749 countsByYear W21404927492022 @default.
• W2140492749 countsByYear W21404927492023 @default.
• W2140492749 crossrefType "journal-article" @default.
• W2140492749 hasAuthorship W2140492749A5001220282 @default.
• W2140492749 hasAuthorship W2140492749A5002515746 @default.
• W2140492749 hasAuthorship W2140492749A5015608281 @default.
• W2140492749 hasAuthorship W2140492749A5019761569 @default.
• W2140492749 hasAuthorship W2140492749A5034002721 @default.
• W2140492749 hasAuthorship W2140492749A5035878833 @default.
• W2140492749 hasAuthorship W2140492749A5053179595 @default.
• W2140492749 hasAuthorship W2140492749A5053918852 @default.
• W2140492749 hasAuthorship W2140492749A5087353638 @default.
• W2140492749 hasBestOaLocation W21404927491 @default.
• W2140492749 hasConcept C121608353 @default.
• W2140492749 hasConcept C126322002 @default.
• W2140492749 hasConcept C150903083 @default.
• W2140492749 hasConcept C154317977 @default.
• W2140492749 hasConcept C167672396 @default.
• W2140492749 hasConcept C202751555 @default.
• W2140492749 hasConcept C203014093 @default.
• W2140492749 hasConcept C207001950 @default.
• W2140492749 hasConcept C2776694085 @default.
• W2140492749 hasConcept C2777701055 @default.
• W2140492749 hasConcept C2777877232 @default.
• W2140492749 hasConcept C2778170410 @default.
• W2140492749 hasConcept C2778297628 @default.
• W2140492749 hasConcept C2778378633 @default.
• W2140492749 hasConcept C2780674031 @default.
• W2140492749 hasConcept C2781303535 @default.
• W2140492749 hasConcept C39347974 @default.
• W2140492749 hasConcept C502942594 @default.
• W2140492749 hasConcept C55493867 @default.
• W2140492749 hasConcept C71924100 @default.

• next